Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma
Open Access
- 16 September 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (43) , 69916-69926
Abstract
Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinomaKeywords
This publication has 73 references indexed in Scilit:
- Fibrolamellar Carcinoma: A Review with Focus on Genetics and Comparison to Other Malignant Primary Liver TumorsSeminars in Liver Disease, 2011
- Epidermal growth factor induces cytokeratin 19 expression accompanied by increased growth abilities in human hepatocellular carcinomaLaboratory Investigation, 2011
- Pathology of Early Hepatocellular Carcinoma: Conventional and Molecular DiagnosisSeminars in Liver Disease, 2010
- Diagnostic role of serum glypican‐3 in differentiating hepatocellular carcinoma from non‐malignant chronic liver disease and other liver cancersJournal of Gastroenterology and Hepatology, 2009
- Cytoplasmic Staining of TTF-1 in the Differential Diagnosis of Hepatocellular Carcinoma vs Cholangiocarcinoma and Metastatic Carcinoma of the LiverAmerican Journal of Clinical Pathology, 2006
- Cytoplasmic Staining of TTF-1 in the Differential Diagnosis of Hepatocellular Carcinoma vs Cholangiocarcinoma and Metastatic Carcinoma of the LiverAmerican Journal of Clinical Pathology, 2006
- The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinomaLaboratory Investigation, 2005
- Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV statusJournal of Hepatology, 2001
- Cloning, expression and chromosomal localization of human Ca2+/calmodulin-dependent protein kinase kinaseJournal of Biomedical Science, 1998
- Cerebroglycan: an integral membrane heparan sulfate proteoglycan that is unique to the developing nervous system and expressed specifically during neuronal differentiationJournal of Cell Biology, 1994